Fluorescent RT in situ PCR detection of MRP1 mRNA in human HCV infected liver

European Journal of Histochemistry

Volumn 45, Issue 1, 2001, Pages 105-108

  Pascolo, L ^a   Bogoni, S ^a   Spano A ^a   Demori, E ^a   Amoroso, A ^a   Crovella, S ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS;

ABC TRANSPORTER; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PRIMER DNA;

CHEMISTRY; FLUORESCENCE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HEPATITIS C; HUMAN; LETTER; METABOLISM; MULTIDRUG RESISTANCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ATP-BINDING CASSETTE TRANSPORTERS; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE; FLUORESCENCE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HEPATITIS C, CHRONIC; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0035224003     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/1620     Document Type: Article

References (8)

1. Dunn S.E., Hughes C.S., LeBlanc G.A., and Cullen J.M.: Overexpression of a p-glycoprotein in hepatocellular carcinomas from woodchuck hepatitis virus-infected woodchucks (Marmota monax). Hepatology 23, 662-668, 1996.
2. Hipfner D.R., Deeley R.G., and Cole S.P.: Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 1467, 359-376, 1999.
3. Hoofnagle J.H.: Management of hepatitis C: current and future perspectives. J. Hepatol. 31, Suppl 1, 264-268, 1999.
4. Kim Y.S., Cho S.W., Lee K.J., Hahm K.B., Wang H.J., Yim H., Jin Y.M and Park C.H.: Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma. Clin. Nucl. Med., 24, 874-879, 1999.
5. Legrand O., Perrot J.Y., Tang R., Simonin G., Gurbuxani S., Zittoun R., and Marie J.P.: Expression of the multidrug resistance-associated protein (MRP) mRNA and prote n in normal peripheral blood and bone marrow haemopoietic cells. Br. J. Haematol. 94, 23-33, 1996.
6. Matsunaga T., Shirasawa H., Hishiki T., Enomoto H., Kouchi K., Ohtsuka Y., Iwai J., Yoshida H., Tanabe M., Kobayashi S., Asano T., Etoh T., Nishi Y., and Ohnuma N: Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behaviour. Jpn. J. Cancer Res. 89, 1276-1283, 1998.
7. Minemura M., Tanimura H., and Tabor E: Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines. Int. J. Oncol. 15, 559-563, 1999.
8. Takeuchi A., Kaneko S., Matsushita E., Urabe T., Shimoda A., and Kobayashi K.: Interferon-alpha modulates resistance to cisplatin in three human hepatoma cell lines. J. Gastroenterol. 34, 351-358, 1999.